HOUSE DOCKET, NO. 112 FILED ON: 1/7/2019
HOUSE . . . . . . . . . . . . . . . No. 1148
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
William J. Driscoll, Jr.
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act regarding Massachusetts drug price relief.
_______________
PETITION OF:
Name: | District/Address: | Date Added: |
William J. Driscoll, Jr. | 7th Norfolk | 1/7/2019 |
Dylan A. Fernandes | Barnstable, Dukes and Nantucket | 1/17/2019 |
Brian W. Murray | 10th Worcester | 1/16/2019 |
Natalie M. Higgins | 4th Worcester | 1/30/2019 |
Denise C. Garlick | 13th Norfolk | 1/29/2019 |
Carmine Lawrence Gentile | 13th Middlesex | 1/27/2019 |
Paul McMurtry | 11th Norfolk | 2/1/2019 |
David M. Rogers | 24th Middlesex | 1/28/2019 |
Michael J. Moran | 18th Suffolk | 1/29/2019 |
Andres X. Vargas | 3rd Essex | 1/31/2019 |
Daniel J. Hunt | 13th Suffolk | 1/29/2019 |
Peter Capano | 11th Essex | 1/16/2019 |
Michael S. Day | 31st Middlesex | 1/28/2019 |
Nika C. Elugardo | 15th Suffolk | 2/3/2019 |
Stephan Hay | 3rd Worcester | 1/24/2019 |
Mary S. Keefe | 15th Worcester | 1/30/2019 |
Liz Miranda | 5th Suffolk | 1/31/2019 |
Tram T. Nguyen | 18th Essex | 1/25/2019 |
Denise Provost | 27th Middlesex | 1/31/2019 |
Carlos González | 10th Hampden | 1/24/2019 |
Tricia Farley-Bouvier | 3rd Berkshire | 1/28/2019 |
James K. Hawkins | 2nd Bristol | 1/31/2019 |
Rebecca L. Rausch | Norfolk, Bristol and Middlesex | 2/1/2019 |
David Allen Robertson | 19th Middlesex | 2/3/2019 |
José F. Tosado | 9th Hampden | 1/31/2019 |
HOUSE DOCKET, NO. 112 FILED ON: 1/7/2019
HOUSE . . . . . . . . . . . . . . . No. 1148
By Mr. Driscoll of Milton, a petition (accompanied by bill, House, No. 1148) of William J. Driscoll, Jr. and others that the Group Insurance Commission and the Office of Medicaid be authorized to enter into agreements with manufacturer of drugs for purchase of prescribed pharmaceuticals. Health Care Financing. |
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 2983 OF 2017-2018.]
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-First General Court
(2019-2020)
_______________
An Act regarding Massachusetts drug price relief.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Chapter 6A of the General Laws is hereby amended by inserting after section 16Y the following section:-
Section 16Z. (a) Notwithstanding any general or special law to the contrary, and insofar as may be permissible under federal law, neither the commonwealth, nor any state administrative agency or other state entity, including, but not limited to, the group insurance commission and the office of Medicaid shall enter into any agreement with the manufacturer of any drug for the purchase of a prescribed drug unless the net cost of the drug, inclusive of cash discounts, free goods, volume discounts, rebates, or any other discounts or credits, as determined by the group insurance commission, is the same as or less than the lowest price paid for the same drug by the United States Department of Veterans Affairs.
(b) The price ceiling described in subsection (a) shall apply to all programs where the commonwealth or any state administrative agency or other state entity is the ultimate payer for the drug, even if it did not purchase the drug directly. The responsible state agency shall enter into additional agreements with drug manufacturers for further price reductions so that the net cost of the drug, as determined by the group insurance commission, is the same as or less than the lowest price paid for the same drug by the United States Department of Veterans Affairs.
(c) All state departments, agencies and other state entities that enter into 1 or more agreements with the manufacturer of any drug for the purchase of prescribed drugs or agreement to pay directly or indirectly for prescribed drugs shall implement this section no later than July 1, 2018.
(d) Each such department agency or other state entity, may adopt administrative rules to implement this section and may seek any waivers of federal law, rule, or regulation necessary to implement this section.